Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vyth

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Pharmaceutisch Weekblad. Scientific Edition|June 25, 1982
Colorimetric determination of tin(II) levels in 99mTc labelling kitsA Vyth
Thrombosis and Haemostasis|June 4, 2009
Angiostasis as a way to improve immunotherapyArjan W Griffioen, Florry A Vyth-Dreese
Leukemia Research|January 1, 1984
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term cultureF A Vyth-Dreese, J E de Vries
International Journal of Cancer|December 15, 1984
Induction of IL-2 production, IL-2 receptor expression and proliferation of T3- T-PLL cells by phorbol esterF A Vyth-Dreese, J E De Vries
Leukemia Research|January 1, 1984
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--II. Inhibition of lymphoproliferative responsesF A Vyth-Dreese, J E de Vries
American Journal of Hospital Pharmacy|October 1, 1986
Aluminum contamination of dialysis and intravenous fluids after asbestos-free depth filtrationA Vyth, L M Stolk, F C Abbad
International Journal of Cancer|July 15, 1983
Enhanced expression of human T-cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin-2F A Vyth-Dreese, J E de Vries
Lancet (London, England)|October 30, 1982
Human T-cell leukemia virus in lymphocytes from T-cell leukemia patient originating from SurinamF A Vyth-Dreese, J E de Vries
Clinical and Experimental Immunology|February 1, 1981
T-cell growth factor-mediated proliferation of lymphocytes from a T-chronic lymphocytic leukaemia patient lacking mitogen and alloantigen responsivenessJ E De Vries, F A Vyth, J Mendelsohn
Pharmaceutisch Weekblad. Scientific Edition|April 29, 1983
Formulation of a stable vidarabine infusion fluidL M Stolk, W Huisman, H D Nordemann, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmaceutisch Weekblad. Scientific Edition|June 25, 1982
Colorimetric determination of tin(II) levels in 99mTc labelling kitsA Vyth
Thrombosis and Haemostasis|June 4, 2009
Angiostasis as a way to improve immunotherapyArjan W Griffioen, Florry A Vyth-Dreese
Leukemia Research|January 1, 1984
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term cultureF A Vyth-Dreese, J E de Vries
International Journal of Cancer|December 15, 1984
Induction of IL-2 production, IL-2 receptor expression and proliferation of T3- T-PLL cells by phorbol esterF A Vyth-Dreese, J E De Vries
Leukemia Research|January 1, 1984
Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--II. Inhibition of lymphoproliferative responsesF A Vyth-Dreese, J E de Vries
American Journal of Hospital Pharmacy|October 1, 1986
Aluminum contamination of dialysis and intravenous fluids after asbestos-free depth filtrationA Vyth, L M Stolk, F C Abbad
International Journal of Cancer|July 15, 1983
Enhanced expression of human T-cell leukemia/lymphoma virus in neoplastic T cells induced to proliferate by phorbol ester and interleukin-2F A Vyth-Dreese, J E de Vries
Lancet (London, England)|October 30, 1982
Human T-cell leukemia virus in lymphocytes from T-cell leukemia patient originating from SurinamF A Vyth-Dreese, J E de Vries
Clinical and Experimental Immunology|February 1, 1981
T-cell growth factor-mediated proliferation of lymphocytes from a T-chronic lymphocytic leukaemia patient lacking mitogen and alloantigen responsivenessJ E De Vries, F A Vyth, J Mendelsohn
Pharmaceutisch Weekblad. Scientific Edition|April 29, 1983
Formulation of a stable vidarabine infusion fluidL M Stolk, W Huisman, H D Nordemann, et al.
Pageof 6